Contribution of Matrix Metalloproteinase-2 Genotypes to Taiwan Pterygium Risk
- PMID: 38418145
- PMCID: PMC10905486
- DOI: 10.21873/invivo.13472
Contribution of Matrix Metalloproteinase-2 Genotypes to Taiwan Pterygium Risk
Abstract
Background/aim: In the literature, the studies about the role of matrix metalloproteinase-2 (MMP-2) in pterygium diagnosis are mainly based on its protein expression. The role of MMP-2 variants has never been examined. The aim of this study was to examine the association of MMP-2 genotypes with pterygium risk.
Materials and methods: MMP-2 rs243865 and rs2285053 were genotyped in 140 pterygium cases and 280 non-pterygium controls by typical polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) genotyping technology.
Results: The genotypic frequency of MMP-2 rs243865 CC, CT and TT were 86.4%, 12.9% and 0.7% in the pterygium group and 81.1%, 17.1% and 1.8% in the non-pterygium group (p for trend=0.3389). The variant CT and TT carriers had a 0.70- and 0.38-fold pterygium risk (95%CI=0.39-1.26 and 0.04-3.25, p=0.2982 and 0.6686, respectively). As for MMP-2 rs2285053, the genotypic frequency of CC, CT and TT were 67.1%, 28.6% and 4.3% in the pterygium group, non-significantly different from those in non-pterygium group (p for trend=0.7081). The CT and TT carriers had a 0.88- and 0.71-fold pterygium risk (95%CI=0.56-1.38 and 0.27-1.88, p=0.6612 and 0.6456, respectively). The allelic analysis results showed that MMP-2 rs243865 variant T allele was not associated with pterygium risk (7.1% versus 10.4%, OR=0.67, 95%CI=0.39-1.13, p=0.1649). As for MMP-2 rs2285053, the T allele was not associated with pterygium risk either (18.6% versus 21.1%, OR=0.85, 95%CI=0.59-1.23, p=0.4136).
Conclusion: The genotypes at MMP-2 rs243865 or rs2285053 played minor role in determining individual susceptibility for pterygium among Taiwanese.
Keywords: Genotype; MMP-2; polymorphism; pterygium.
Copyright © 2024, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Conflict of interest statement
All the Authors declare no conflicts of interest regarding this study.
Figures
Similar articles
-
Impacts of Matrix Metalloproteinase-2 Promoter Genotypes on Breast Cancer Risk.Cancer Genomics Proteomics. 2024 Sep-Oct;21(5):502-510. doi: 10.21873/cgp.20467. Cancer Genomics Proteomics. 2024. PMID: 39191502 Free PMC article.
-
Association of Matrix Metalloproteinase-2 Genotypes With Prostate Cancer Risk.Anticancer Res. 2023 Jan;43(1):343-349. doi: 10.21873/anticanres.16169. Anticancer Res. 2023. PMID: 36585186
-
Impacts of Matrix Metalloproteinase-11 Genotypes on Pterygium Risk.Anticancer Res. 2024 Nov;44(11):4825-4831. doi: 10.21873/anticanres.17308. Anticancer Res. 2024. PMID: 39477282
-
Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review.Gene. 2016 Sep 1;589(1):81-89. doi: 10.1016/j.gene.2016.05.028. Epub 2016 May 21. Gene. 2016. PMID: 27222481 Review.
-
Association between the Matrix Metalloproteinase-9 rs3918242 Polymorphism and Ischemic Stroke Susceptibility: A Meta-Analysis.J Stroke Cerebrovasc Dis. 2017 May;26(5):1136-1143. doi: 10.1016/j.jstrokecerebrovasdis.2016.12.036. Epub 2017 Feb 28. J Stroke Cerebrovasc Dis. 2017. PMID: 28258806 Review.
Cited by
-
Contribution of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 to Upper Tract Urothelial Cancer Risk in Taiwan.Life (Basel). 2024 Jun 26;14(7):801. doi: 10.3390/life14070801. Life (Basel). 2024. PMID: 39063556 Free PMC article.
-
Impact of Vitamin D Receptor Genotypes on Taiwan Asthma Risk.In Vivo. 2025 Jul-Aug;39(4):1852-1863. doi: 10.21873/invivo.13985. In Vivo. 2025. PMID: 40579017 Free PMC article.
-
Impacts of Matrix Metalloproteinase-9 Promoter Genotypes on Asthma Risk.In Vivo. 2024 Sep-Oct;38(5):2144-2151. doi: 10.21873/invivo.13677. In Vivo. 2024. PMID: 39187355 Free PMC article.
-
Impacts of Matrix Metalloproteinase-2 Promoter Genotypes on Breast Cancer Risk.Cancer Genomics Proteomics. 2024 Sep-Oct;21(5):502-510. doi: 10.21873/cgp.20467. Cancer Genomics Proteomics. 2024. PMID: 39191502 Free PMC article.
-
Impact of Vitamin D Receptor Genotypes on Taiwan Hallux Valgus.In Vivo. 2024 Jul-Aug;38(4):1601-1608. doi: 10.21873/invivo.13610. In Vivo. 2024. PMID: 38936889 Free PMC article.
References
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous